logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Saisheng Pharmaceutical: Obtained the issued "Drug Production License"

date
07/11/2025
Sai Sheng Pharmaceutical announced that it has recently received a new "Drug Production License" issued by the Beijing Municipal Drug Administration. The new "Drug Production License" is valid until November 4, 2030.
Latest
3 m ago
Shunfeng Holdings: Shareholder Liu Jilu and persons acting in concert internally transfer 7 million shares.
3 m ago
Quanzhou Bank is approved to issue capital supplement tools not exceeding 2 billion yuan.
4 m ago
Shenzhen Stock Exchange: This week we will focus on monitoring the recent severe abnormal price fluctuations of "*ST Dongyi" and "ST Zhongdi".
5 m ago
Xiaopeng Yuan Tingting: The second generation of VLA will understand the world like a human being and will be mass produced in the first quarter of next year.
5 m ago
Wang Xiao, CEO of Sagitar Innovation: EM platform products have been designated for 45 models by 8 top car companies.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.